Background It is controversial whether prolonged antibiotic treatment is effective for patients
in whom symptoms persist after the recommended antibiotic treatment for acute Lyme …

Objective Assessment of the inter and intraobserver variability of the modified Rodnan (m-Rodnan)
total skin thickness score by clinical palpation [a commonly used outcome measure …

Objective To describe a new systemic lupus erythematosus (SLE) responder index (SRI) based
on a belimumab phase II SLE trial and demonstrate its potential utility in SLE clinical trials…

Objective To document disease activity and functional status in patients with scleroderma (systemic
sclerosis [SSc]) and Raynaud's phenomenon (RP) and to determine the sensitivity to …

Objective To test the hypothesis that systemic sclerosis (SSc) patients taking high‐dose D‐penicillamine
(D‐Pen) would have greater softening of skin, lower frequency of renal crisis, …

Objective To study the clinical implications of a skin thickness score ≥20 at first visit and of
softening of sclerodermatous skin in a cohort of systemic sclerosis (SSc) patients with diffuse …

Thirty‐seven patients with psoriatic arthritis were entered into a 12‐week prospective, controlled,
double‐blind multicenter trial comparing placebo and oral pulse methotrexate therapy. …

Purpose: To provide a quantitative and qualitative evaluation of the predictive value of the
laboratory diagnosis of Lyme disease and to use the resultant data to formulate guidelines for …

Objective The reported frequency of scleroderma M01‐R renal crisis (SRC) in diffuse systemic
sclerosis (SSc; scleroderma) is 15–20%. Early use of angiotensin‐converting enzyme (…

Introduction This trial evaluated the safety, biologic activity, and pharmacokinetics of belimumab,
a fully human monoclonal antibody that inhibits the biologic activity of the soluble form …